WallStreetZenWallStreetZen

NASDAQ: KPTI
Karyopharm Therapeutics Inc Stock Ownership - Who owns Karyopharm Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Karyopharm Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Reshma RangwalaEVP Chief Medical Officer2024-04-226,789$1.17
$7.94kSell
Richard A. PaulsonPresident and CEO2024-04-043,563$1.29
$4.60kSell
Richard A. PaulsonPresident and CEO2024-03-053,573$1.30
$4.64kSell
Richard A. PaulsonPresident and CEO2024-03-0119,374$1.20
$23.25kSell
Reshma RangwalaEVP Chief Medical Officer2024-03-015,969$1.20
$7.16kSell
Sohanya Roshan ChengEVP Chief Commercial Officer2024-03-015,109$1.20
$6.13kSell
Michael ManoSVP General CounselSecretary2024-03-013,576$1.20
$4.29kSell
Stuart PoultonEVP Chief Development Officer2024-03-016,155$1.20
$7.39kSell
Michael MasonEVP CFO Treasurer2024-03-016,162$1.20
$7.39kSell
Sohanya Roshan ChengEVP Chief Commercial Officer2024-02-2921,840$1.17
$25.55kSell

1 of 4

KPTI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KPTI insiders and whales buy or sell their stock.

KPTI Shareholders

What type of owners hold Karyopharm Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Chione Ltd14.13%16,258,079$17.72MInsider
Blackrock Inc8.75%10,071,677$10.98MInstitution
Vanguard Group Inc7.57%8,710,158$9.49MInstitution
Avidity Partners Management LP7.21%8,298,570$9.05MInstitution
Plio Ltd5.51%6,336,946$6.91MInsider
Marcin Czernik5.15%5,930,939$6.46MInsider
Palo Alto Investors LP4.43%5,102,193$5.56MInstitution
Citadel Advisors LLC2.70%3,101,399$3.38MInstitution
Geode Capital Management LLC2.07%2,382,428$2.60MInstitution
Gsa Capital Partners LLP2.03%2,337,985$2.55MInstitution

1 of 3

KPTI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KPTI63.84%32.73%Net SellingNet Selling
COYA19.41%14.62%Net Buying
AMLX52.42%47.58%Net BuyingNet Selling
PDSB22.71%31.97%
SGMT39.98%60.02%Net BuyingNet Buying
View Top Biotech Stocks

Karyopharm Therapeutics Stock Ownership FAQ

Who owns Karyopharm Therapeutics?

Karyopharm Therapeutics (NASDAQ: KPTI) is owned by 63.84% institutional shareholders, 32.73% Karyopharm Therapeutics insiders, and 3.43% retail investors. Chione Ltd is the largest individual Karyopharm Therapeutics shareholder, owning 16.26M shares representing 14.13% of the company. Chione Ltd's Karyopharm Therapeutics shares are currently valued at $17.23M.

If you're new to stock investing, here's how to buy Karyopharm Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.